Delivery Order SPE2DB20D3101-SPE2DB24FRHW5
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIVALO 2 MG TABLET 90S. The contract has a ceiling value of $1,273.59 and runs through August 6, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. federal government. The $4,449.69 fixed-price contract is for the delivery of Livalo 2 mg tablets. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a broad range of...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6MBP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,806.70 firm fixed-price delivery order is for the supply of LIVALO 1 MG TABLET 90S, with a period of performance through May 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,262.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of LIVALO 1 MG TABLET 90S to support military treatment programs and facilities. This delivery order contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,219.94 firm fixed-price delivery order is for the supply of 90 tablets of the prescription medication LIVALO 2 MG. The contract has an ultimate completion date of July 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4566357429 LIVALO 2 MG TABLET 90S. The contract has a firm-fixed-price delivery order valued at $11,875.13 with a completion date of November 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026,...
- This federal contract award, valued at $89,529.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,252.93 Firm Fixed Price Delivery Order covers the provision of LIVALO 1 MG TAB 90S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025 and was awarded on December 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,287.44 firm-fixed-price delivery order is for the supply of LIVALO 1 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,114.22, is for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type and has a completion date of November 15, 2023. The contract was awarded on November 14, 2023, and there was no set-aside designation, indicating open...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRHW5Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation. The $1,262.94 contract is for the supply of the pharmaceutical product LIVALO 2 MG TABLET 90S. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly to the Department of Defense (DoD) and the Department of Veterans Affairs (VA). This award is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical and medical products to DLA facilities supporting the DoD worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/30/24 |